SEC Form 4 · accession 0001493152-16-015198
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Alan Berg
Director · 10% Owner
Period of report
Nov 14, 2016
Accepted (ET)
Nov 16, 2016 · 8:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 14, 2016 | P | 1,200 | $7.20 | A | 418,580 | I | See Footnote |
| Common StockF1 | Nov 15, 2016 | P | 500 | $7.33 | A | 419,080 | I | See Footnote |
| Common StockF1 | Nov 16, 2016 | P | 1,200 | $7.21 | A | 420,080 | I | See Footnote |
| Common StockF1 | Nov 16, 2016 | P | 1,000 | $7.23 | A | 421,280 | I | See Footnote |
| Common StockF1 | Nov 16, 2016 | P | 720 | $7.26 | A | 422,000 | I | See Footnote |
| Common StockF1 | Nov 16, 2016 | P | 500 | $7.28 | A | 422,500 | I | See Footnote |
| Common StockF1 | Nov 16, 2016 | P | 500 | $7.25 | A | 423,000 | I | See Footnote |
| Common Stock | holding | — | — | — | 10,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.